Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Amyotrophic Lateral Sclerosis - Pipeline Review, H2 2020, provides an overview of the Amyotrophic Lateral Sclerosis (Central Nervous System) pipeline landscape. Amyotrophic...
"US Alzheimer’s Disease Drug Market, Dosage, Price & Clinical Trials Insight 2026" Report Highlights: • US Alzheimer’s Disease Drug Market Opportunity: > US$ 5 Billion • US Accounts For More Than 40% of Global Alzheimer’s Disease Drug Market • US Alzheimer’s Disease Drug Clinical Trials: 200 Drugs in Pipeline •...
‘Amyotropic Lateral Sclerosis (ALS) - Epidemiology Forecast – 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Amyotropic Lateral Sclerosis (ALS) epidemiology in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan. Geographies Covered • The...
Dementia Associated With Alzheimer’s Disease - Global Clinical Trials Review, H2, 2020 Summary clinical trial report, “Dementia Associated With Alzheimer’s Disease - Global Clinical Trials Review, H2, 2020" provides an overview of Dementia Associated With Alzheimer’s Disease Clinical trials scenario....
Major players in the Alzheimer’s disease treatment market are Allergan, Eisai Co. Ltd., Novartis AG, Pfizer Inc., Merz Pharma, H. Lundbeck A/S Biogen, AstraZeneca, and F. Hoffmann-La Roche Ltd. The global Alzheimer’s disease treatment market is expected to decline from $3.46 billion in 2019 to $3.42 billion in 2020 at a compound annual...
The Amyotrophic Lateral Sclerosis Treatment is expected to register a CAGR of 5.5% during the forecast period. This is attributing the rising prevalence of amyotrophic lateral sclerosis diseases and the growing geriatric population worldwide. As per the Centers for Disease Control and Prevention, in 2016, amyotrophic lateral sclerosis (ALS)...
Spinocerebellar Ataxia (SCA) - Pipeline Review, H2 2020 Summary latest Pharmaceutical and Healthcare disease pipeline guide Spinocerebellar Ataxia - Pipeline Review, H2 2020, provides an overview of the Spinocerebellar Ataxia (Genetic Disorders) pipeline landscape. Spinocerebellar ataxias...
Insulin Like Growth Factor I - Pipeline Review, H2 2020 Summary Insulin Like Growth Factor I (Mechano Growth Factor or Somatomedin C or IGF1) - Insulin-like growth factor 1 (IGF-1) also called somatomedin C is a protein encoded by the IGF1 gene. It stimulates glucose transport in bone-derived osteoblastic...
Insulin Like Growth Factor II - Pipeline Review, H2 2020 Summary According to the recently published report ’Insulin Like Growth Factor II - Pipeline Review, H2 2020’; Insulin Like Growth Factor II (Somatomedin A or T3M 11 Derived Growth Factor or IGF2) pipeline Target constitutes close to 7 molecules....
Protein Kinase C Epsilon Type - Pipeline Review, H2 2020 Summary Protein Kinase C Epsilon Type (nPKC Epsilon or PRKCE or EC 2.7.11.13) - Protein kinase C (PKC) is an enzyme belonging to a family of serine- and threonine-specific protein kinases that is activated by calcium and the second messenger...